BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10862016)

  • 1. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro.
    Faust RA; Tawfic S; Davis AT; Bubash LA; Ahmed K
    Head Neck; 2000 Jul; 22(4):341-6. PubMed ID: 10862016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of cancer cells to molecular interruption of the CK2 signal.
    Wang H; Davis A; Yu S; Ahmed K
    Mol Cell Biochem; 2001 Nov; 227(1-2):167-74. PubMed ID: 11827168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.
    Gapany M; Faust RA; Tawfic S; Davis A; Adams GL; Ahmed K
    Mol Med; 1995 Sep; 1(6):659-66. PubMed ID: 8529132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells.
    Faust RA; Niehans G; Gapany M; Hoistad D; Knapp D; Cherwitz D; Davis A; Adams GL; Ahmed K
    Int J Biochem Cell Biol; 1999 Sep; 31(9):941-9. PubMed ID: 10533285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation.
    Faust RA; Gapany M; Tristani P; Davis A; Adams GL; Ahmed K
    Cancer Lett; 1996 Mar; 101(1):31-5. PubMed ID: 8625279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
    J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
    Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
    Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells.
    Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS
    J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
    Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
    Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of catalytic and regulatory subunits of protein kinase CK2 by antisense oligonucleotide treatment of neuroblastoma cells.
    Ulloa L; Díaz-Nido J; Avila J
    Cell Mol Neurobiol; 1994 Oct; 14(5):407-14. PubMed ID: 7621503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CK2 for cancer therapy.
    Ahmad KA; Wang G; Slaton J; Unger G; Ahmed K
    Anticancer Drugs; 2005 Nov; 16(10):1037-43. PubMed ID: 16222144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
    Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
    Endo S; Zeng Q; Burke NA; He Y; Melhem MF; Watkins SF; Lango MN; Drenning SD; Huang L; Rubin Grandis J
    Gene Ther; 2000 Nov; 7(22):1906-14. PubMed ID: 11127578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
    He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
    J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
    Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ
    Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
    Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.